Clinical Trials in Oncology West Coast 2026

Choose Avance Clinical for Oncology Clinical Trials

Your next trial deserves a partner with proven oncology experience, extensive international reach, and the agility which biotech sponsors depend on. As a specialist oncology Contract Research Organization (CRO) with a dedicated Oncology Center of Excellence, we leverage a global footprint, early‑phase operational excellence, and a strong focus on cancer research.

Here are a few key advantages that set Avance Clinical apart in oncology clinical development:

• Over 100 oncology trials conducted in the past five years, including multiple repeat collaborations – delivering focused early‑phase execution across a wide range of malignancies while improving learning curves, feasibility, and protocol design.
• Comprehensive support from Phase I/early phase through Phase II+ and Late phase, across Australia, Asia, and the United States.
• Deep experience across both hematological malignancies and solid tumors, including NSCLC, melanoma, ovarian, glioblastoma, and rare oncology indications.
• Strategic global footprint for a seamless multi‑region development pathway, including Australia’s efficient start‑up environment and R&D rebate ecosystem, expanded North American operations, and strong presence across Asia.